NuVasive, Inc. (NASDAQ:NUVA)

CAPS Rating: 3 out of 5

A medical device company focused on the design, development and marketing of products for the surgical treatment of spine disorders.

Recs

0
Player Avatar stockguy07 (< 20) Submitted: 9/2/2008 12:52:23 PM : Outperform Start Price: $48.50 NUVA Score: -67.19

TM

Featured Broker Partners


Advertisement